Marc Rubin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 11,900 shares at $6.58 ($78K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $78k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTNP | BUY | 2018-09-25 | $100K | — | Filing → |
| GALT | SELL | 2018-09-04 | $353K | — | Filing → |
| GALT | BUY | 2017-12-08 | $13K | — | Filing → |